5432522025-10-012025-12-315432522025-04-012025-12-315432522025-10-012025-12-31in-capmkt:OtherExpenses1Member5432522025-10-012025-12-31in-capmkt:OtherExpenses2Member5432522025-04-012025-12-31in-capmkt:OtherExpenses1Member5432522025-04-012025-12-31in-capmkt:OtherExpenses2Member5432522025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15432522025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15432522025-10-012025-12-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares543252FAIRCHEMORNOTLISTEDINE0DNW01011Fairchem Organics LimitedMain BoardEquity2025-04-012026-03-312026-02-062026-01-23INRLakhsQuarterlyThird quarterSingle segmentSpeciality Chemicals2026-02-0615:20:002026-02-0616:00:00Declaration of unmodified opinionfalsefalseNot Applicable2025-10-012025-12-31UnauditedStandalone10013400002574000100391400074867400005884800060006000961700027959000920340009971380006776000-8827000-2051000-25450001465000-10800000-9710000000-9710004059000308800013020900010-0.07-0.0700-0.07-0.07000Notes: <BR> 1. The above unaudited financial results, as reviewed by Audit Committee, are subsequently approved by the Board of Directors at their meetings held on February 06, 2026. The Statutory Auditors have performed limited review of the Company's financial results for the quarter and nine months ended on December 31, 2025. The Statutory Auditors have expressed an unmodified review conclusion. <BR> <BR> 2. The unaudited financial results of the Company have been prepared in accordance with Indian Accounting Standards (‘Ind AS’) prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and in terms of the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. <BR> <BR> 3. The Company is engaged in the business of manufacturing of speciality chemicals viz. Oleo Chemicals and Intermediate Nutraceuticals. Considering the nature of Company’s business, as well as based on review of operating results by the chief operating decision maker to make decisions about resource allocation and performance measurement, there is only one reportable business segment in accordance with the requirements of IND AS 108 – “Operating Segments”. <BR> <BR> Sr. <BR> No. Particulars (Rs. In Lakhs) <BR> Quarter ended Nine Months ended Year ended <BR> 31-Dec-2025 30-Sep-2025 31-Dec-2024 31-Dec-2025 31-Dec-2024 31-Mar-2025 <BR> Unaudited Unaudited Unaudited Unaudited Unaudited Audited <BR> I Segment Revenue <BR> Speciality Chemicals 10,013.40 11,152.27 11,357.08 34,271.98 41,711.77 53,789.84 <BR> II Segment Results <BR> Speciality Chemicals 161.51 178.36 563.80 601.56 3,151.18 3,352.99 <BR> Less: Finance cost (96.17) (60.96) (92.63) (257.65) (275.63) (366.63) <BR> Add: Interest Income 2.42 0.36 0.43 3.17 5.26 5.68 <BR> Profit Before Tax and Exceptional Items 67.76 117.76 471.60 347.08 2,880.81 2,992.04 <BR> Less: Exceptional Items (Note 5) (88.27) - - (88.27) - - <BR> Profit Before Tax (20.51) 117.76 471.60 258.81 2,880.81 2,992.04 <BR> III Segment Assets <BR> Speciality Chemicals 38,056.27 38,838.51 36,344.18 38,056.27 36,344.18 40,182.88 <BR> IV Segment Liabilities <BR> Speciality Chemicals 8,621.01 9,434.16 6,193.16 8,621.01 6,193.16 9,979.82 <BR> <BR> <BR> <BR> 4. The Company does not have any subsidiary/associate/joint venture company as on December 31,2025. <BR> <BR> 5. The Government of India has implemented four new Labour Codes, including the Codes on Wages,2019 w.e.f. November 21, 2025. The Ministry of Labour & Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations. Based on management’s assessment, actuarial valuation and in line with ICAI guidance, the Company has recognised additional employee benefit obligation of Rs.88.27 Lakhs which has been disclosed as an Exceptional item in the financial results for the quarter and nine months ended December 31, 2025. The Company continues to monitor the finalization of Central/ State Rules and clarifications from the Government on other aspects of the Labour Codes and would provide appropriate accounting effect as and when such clarifications are issued/rules are notified. <BR> <BR> 6. The Members of the Company through Postal Ballot approved the Special Resolution dated December 26, 2025, for Buyback of upto 4,25,000 fully paid-up Equity Shares of face value of Rs. 10/- each, representing 3.26% of the total number of the Equity Shares in the paid-up Share Capital of the Company as on March 31, 2025, through a Tender Offer route, at a price of Rs. 800/- per Equity Share, payable in cash, for an aggregate amount not exceeding Rs. 34 Crores. The Buyback offer was commenced on January 8, 2026, and closed on January 14, 2026. <BR> The settlement of all valid bids was completed on January 21, 2026, and 4,25,000 Equity Shares, which were tendered and accepted in Buyback were extinguished on January 27, 2026. <BR> <BR> 7. Investors can view the unaudited financial results of the Company for the quarter and nine months ended on December 31, 2025 on the Company's website www.fairchem.in, on the website of the BSE www.bseindia.com and on the website of NSE www.nseindia.com. <BR> <BR> <BR> For and on behalf of the Board of Directors, <BR> For Fairchem Organics Limited, <BR> <BR> <BR> <BR> <BR> Place: Chekhala, Taluka Sanand, Nahoosh Jariwala <BR> Dist. AHMEDABAD Chairman and Managing Director <BR> Date: February 06, 2026 (DIN: 00012412) <BR> 2025-04-012025-12-31UnauditedStandalone342719800076530003434851000264310300001214120001738520002576500083063000352948000340014300034708000-882700025881000-43500078290007394000018487000000018487000238700020874000130209000101.421.42001.421.42000Power and Fuel38698000Other Expenses53336000Power and Fuel171001000Other Expenses181947000Remeasurement (Losses)/Gains on Post Employment Defined Benefit Plans54250005425000Remeasurement (Losses)/Gains on Post Employment Defined Benefit Plans31900003190000136600080300040590002387000UnauditedtrueB S R and Co.true2026-04-30